Our core cellular infusion therapy harnesses the healing properties of Umbilical Cord-derived Mesenchymal Stem Cells (UC-MSCs) to combat the effects of aging.
Clinical studies of these multifunctional cells have shown increased physical performance, improved quality of life, and reduced inflammation.
Our advanced in-house laboratory produces top-quality mesenchymal stem cells sourced from meticulously selected umbilical cords. These cells are verified for their exceptional differentiation capabilities and cellular attributes using flow cytometry. Additionally, they are rigorously screened to ensure they are devoid of infectious agents.
Renowned for their distinctive attributes, these superior cells possess a remarkable ability to migrate towards inflamed and damaged tissues, where they interact with host cells to modulate immune responses, curtail inflammation, and stimulate tissue regeneration by activating resident stem cells.
Despite their genetic variance from the host, these mesenchymal stem cells are recognized for their minimal immune rejection due to the immune system's inherent tolerance towards them. Numerous instances in scientific literature underscore their efficacy in enhancing various specific ailments and age-related frailty in human subjects.
© 2026 RMI Regenerative Medicine Institute Costa Rica
